PHF23 Inhibitors

PHF23 inhibitors are a collection of chemicals that primarily exert their effects by modulating chromatin dynamics and histone modifications. In the context of PHF23, these chromatin changes can influence its binding affinity, interactions, and functionality. The HDAC inhibitors, Trichostatin A and Vorinostat, increase histone acetylation, a modification that can potentially disrupt PHF23's interaction with chromatin. Similarly, 5-Aza-2'-deoxycytidine, a DNMT inhibitor, might alter the DNA sites or chromatin regions that PHF23 targets by modifying the methylation pattern.

EPZ004777 and EPZ5676 are DOT1L inhibitors that target histone methylation, an essential chromatin mark. Changes in these marks can potentially redirect or repel PHF23 from its typical interaction sites. G9a/GLP inhibitors like UNC0638 and BIX-01294, as well as PRC2 inhibitors like EED226 and EPZ011989, function by altering the methylation landscape and chromatin compaction, respectively. Such changes can affect the chromatin's overall structure, influencing where and how PHF23 interacts. The EZH2 inhibitors, GSK126 and GSK343, also target the methylation state, providing another avenue to modulate PHF23's interaction dynamics.